Martin Gregory Scott 4
4 · Ionetix Corp / DE / · Filed Apr 22, 2026
Research Summary
AI-generated summary of this filing
Ionetix Director Martin Scott Receives Stock Awards
What Happened
Martin Gregory Scott, a director of Ionetix, was granted/received a total of 349,514 shares of the issuer's common stock on April 9, 2026. The awards consist of 180,291 shares issued as merger consideration and multiple derivative awards (totaling 169,223 shares) issued in connection with converted option awards. No per-share price is reported (listed as N/A); these were equity awards and option conversions tied to the Merger closing.
Key Details
- Transaction date: April 9, 2026. Form 4 filed April 22, 2026 (filed after the typical 2-business-day window).
- Total shares received: 349,514 (180,291 merger consideration + 169,223 derivative/option-related shares).
- Price: N/A (awards/merger consideration; not an open-market purchase or sale).
- Shares owned after transaction: not disclosed in the filing.
- Notable footnotes:
- Merger consideration: each Legacy Ionetix share converted into 0.5014 shares of the issuer (footnote F1). The Merger closed April 9, 2026.
- Several awards were received in exchange for Legacy Ionetix options adjusted by the conversion ratio (F3). Some options are fully vested (F2); others vest monthly over 48 months beginning March 2026 (F4, F5).
Context
These entries are awards/conversions tied to the company’s April 9, 2026 merger (not open-market buys or sales). Derivative entries reflect converted/exchanged options rather than exercised-for-cash sales; vesting terms vary by grant. The filing date is later than the usual 2-business-day Form 4 deadline, which the company reported with this filing.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-09+180,291→ 180,291 total - Award
Stock Option (Right to Buy)
[F3][F2]2026-04-09+18,803→ 18,803 totalExercise: $0.38Exp: 2029-05-16→ Common Stock (18,803 underlying) - Award
Stock Option (Right to Buy)
[F3][F2]2026-04-09+25,070→ 25,070 totalExercise: $0.38Exp: 2030-06-08→ Common Stock (25,070 underlying) - Award
Stock Option (Right to Buy)
[F3][F2]2026-04-09+25,070→ 25,070 totalExercise: $0.42Exp: 2031-03-11→ Common Stock (25,070 underlying) - Award
Stock Option (Right to Buy)
[F3][F2]2026-04-09+25,070→ 25,070 totalExercise: $0.98Exp: 2035-03-26→ Common Stock (25,070 underlying) - Award
Stock Option (Right to Buy)
[F3][F4]2026-04-09+50,140→ 50,140 totalExercise: $0.98Exp: 2035-03-26→ Common Stock (50,140 underlying) - Award
Stock Option (Right to Buy)
[F3][F5]2026-04-09+25,070→ 25,070 totalExercise: $0.98Exp: 2035-03-16→ Common Stock (25,070 underlying)
Footnotes (5)
- [F1]Received in connection with the Issuer's merger (the "Merger") with Ionetix Corporation ("Legacy Ionetix") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated as of April 9, 2026 (the "Merger Agreement"), by and among the Issuer (f/k/a JDEV Acquisition Corp.), JDEV Merger Subsidiary and Legacy Ionetix. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Ionetix common stock was entitled to receive 0.5014 shares of the Issuer's Common Stock. The Merger closed on April 9, 2026.
- [F2]The stock option is fully vested and exercisable.
- [F3]Received in connection with the Merger in exchange for options to acquire shares of Legacy Ionetix common stock adjusted by the Conversion Ratio.
- [F4]The stock option vests in 48 monthly installments beginning on March 27, 2026.
- [F5]The stock option vests in 48 monthly installments beginning on March 17, 2026.